EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advancing clinical trial equity through integration of telehealth and decentralized treatment

Eleanor Brown iD, George Albert Fisher, Andrew Shelton, Daniel T Chang, Erqi Pollom

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Eleanor Brown und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA. Hauptthemen laut MEDLINE: Telemedicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innovative strategies to increase clinical trial accessibility and equity are needed. We conducted a retrospective review of a phase II investigator-initiated trial to determine whether the modification of clinical trial design to decentralize study treatment can improve trial accessibility among underrepresented groups. Sociodemographic characteristics, including area deprivation indices, as well as study site travel distance, time, and costs were compared between enrolled participants who received chemotherapy locally and participants who did not. Participants who received chemotherapy locally lived substantially farther from the study site (median = 95.90 vs 25.20 miles, P = .004), faced a greater time burden traveling to the study site (median = 115.00 vs 34.00 minutes, P = .002), and had higher travel-related costs for a single trip to the study site (median = $62.81 vs $16.51, P = .004). This study highlights opportunities for alleviating financial and time burdens associated with clinical trial participation, promoting equity in clinical research. Trial Registration: ClinicalTrials.gov identifier: NCT04380337.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelemedicineHumansRetrospective StudiesFemaleMaleMiddle AgedTravelClinical Trials, Phase II as TopicHealth Services AccessibilityTime FactorsAdultNeoplasmsAntineoplastic AgentsAged

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Department of Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Department of Radiation Oncology, Michigan Medicine, Ann Arbor, MI, USA.

ORCID-Profile: Eleanor Brown

Zitieren

APA

Brown, E., Fisher, G. A., Shelton, A., Chang, D. T., & Pollom, E. (2024). Advancing clinical trial equity through integration of telehealth and decentralized treatment. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae050

Vancouver

Brown E, Fisher GA, Shelton A, Chang DT, Pollom E. Advancing clinical trial equity through integration of telehealth and decentralized treatment. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae050

BibTeX
@article{Brown2024,
  author = {Brown, Eleanor and Fisher, George Albert and Shelton, Andrew and Chang, Daniel T and Pollom, Erqi},
  title = {Advancing clinical trial equity through integration of telehealth and decentralized treatment},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae050}
}
Kostenlos starten →